Blue Owl Capital Holdings as of June 30, 2024
Portfolio Holdings for Blue Owl Capital Holdings
Blue Owl Capital Holdings holds 41 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Cullinan Oncology (CGEM) | 9.9 | $36M | 2.0M | 17.44 | |
Pliant Therapeutics (PLRX) | 9.0 | $32M | 3.0M | 10.75 | |
Owl Rock Capital Corporation (OBDC) | 8.7 | $31M | 2.0M | 15.36 | |
Klaviyo Com Ser A (KVYO) | 8.3 | $30M | 1.2M | 24.89 | |
Larimar Therapeutics (LRMR) | 7.8 | $28M | 3.9M | 7.25 | |
Engene Holdings (ENGN) | 6.4 | $23M | 2.4M | 9.43 | |
Tourmaline Bio (TRML) | 6.1 | $22M | 1.7M | 12.86 | |
Evercommerce (EVCM) | 5.0 | $18M | 1.6M | 10.98 | |
Acelyrin (SLRN) | 3.6 | $13M | 2.9M | 4.41 | |
Repare Therapeutics Ord (RPTX) | 3.1 | $11M | 3.4M | 3.30 | |
Ultragenyx Pharmaceutical (RARE) | 3.1 | $11M | 268k | 41.10 | |
Context Therapeutics (CNTX) | 2.9 | $10M | 5.2M | 2.00 | |
Disc Medicine (IRON) | 2.7 | $9.7M | 215k | 45.07 | |
Toast Cl A (TOST) | 2.3 | $8.3M | 323k | 25.77 | |
E2open Parent Holdings Com Cl A (ETWO) | 2.1 | $7.4M | 1.7M | 4.49 | |
Keros Therapeutics (KROS) | 2.0 | $7.2M | 158k | 45.70 | |
Ikena Oncology (IKNA) | 1.9 | $6.8M | 4.1M | 1.65 | |
Sagimet Biosciences Com Ser A (SGMT) | 1.6 | $5.7M | 1.7M | 3.42 | |
Mineralys Therapeutics (MLYS) | 1.5 | $5.3M | 450k | 11.70 | |
Viking Therapeutics (VKTX) | 1.4 | $5.0M | 95k | 53.01 | |
Inozyme Pharma (INZY) | 1.4 | $5.0M | 1.1M | 4.46 | |
Starwood Property Trust SHS (STWD) | 1.2 | $4.3M | 227k | 18.94 | |
Pyxis Oncology Common Stock (PYXS) | 1.0 | $3.5M | 1.0M | 3.31 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.9 | $3.2M | 898k | 3.60 | |
Aquestive Therapeutics (AQST) | 0.8 | $3.0M | 1.1M | 2.60 | |
Compass Therapeutics (CMPX) | 0.8 | $2.8M | 2.8M | 1.00 | |
Adc Therapeutics Sa SHS (ADCT) | 0.6 | $2.3M | 734k | 3.16 | |
Omega Therapeutics Common Stock (OMGA) | 0.6 | $2.2M | 1.1M | 2.07 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.6 | $2.2M | 55k | 39.27 | |
Immunovant (IMVT) | 0.6 | $2.1M | 80k | 26.40 | |
Syros Pharmaceuticals Com New (SYRS) | 0.5 | $1.8M | 341k | 5.16 | |
Janux Therapeutics (JANX) | 0.5 | $1.7M | 40k | 41.89 | |
Celcuity (CELC) | 0.3 | $1.1M | 65k | 16.38 | |
Blend Labs Cl A (BLND) | 0.2 | $853k | 362k | 2.36 | |
Gohealth Cl A New (GOCO) | 0.2 | $815k | 83k | 9.78 | |
Engene Holdings *w Exp 10/31/202 (ENGNW) | 0.2 | $608k | 51k | 11.89 | |
Plum Acquisition Corp Iii Unit 03/31/2028 (PLMJU) | 0.1 | $324k | 70k | 4.63 | |
Desktop Metal Com Cl A (DM) | 0.1 | $310k | 750k | 0.41 | |
Precision Biosciences Com New (DTIL) | 0.1 | $197k | 20k | 9.73 | |
Geron Corporation (GERN) | 0.0 | $101k | 24k | 4.24 | |
Plum Acquisition Corp Iii *w Exp 03/31/202 (PLMJW) | 0.0 | $47k | 667k | 0.07 |